Table 2.
Group B: Patients with adverse childhood experiences with 0–3 medically unexplained symptoms.
| Patient (n = 27) | Age (Years) | Sex | Medically-Unexplained Symptoms | Other Medical Problems | Duration of Medical Symptoms | Total ACE Score | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Executive Dysfunction | Sleep Problems | Autonomic Symptoms | Emotional Dysregulation | Digestive/Urinary Problems | Somatization | ||||||
| 1 | 16 | M | Cognitive dysfunction | None | None | None | None | None | Sickle cell disease, stroke, moyamoya syndrome | 2 years | 1 |
| 2 | 10 | F | None | None | Dizziness, syncope | Depression | None | Headaches, leg pain | None | 2-months | 1 |
| 3 | 14 | F | None | None | None | Depression | None | None | Generalized epilepsy | 1-year | 1 |
| 4 | 14 | F | None | None | Migraine | Depression | None | None | Epilepsy | 2-years | 1 |
| 5 | 7 | M | None | None | None | None | None | Daily headache | None | 1 year | 0 * |
| 6 | 11 | M | Attention problems | None | None | None | None | None | Tics | 5 years | 1 |
| 7 | 12 | F | None | Insomnia | None | Anxiety, depression, OCD | None | None | Trichotillomania tics, asthma, eczema | 7 years | 1 |
| 8 | 17 | M | Attention problems | None | Migraine | None | None | None | None | 5 years | 2 |
| 9 | 15 | M | Cognitive dysfunction | Insomnia | None | Depression, anxiety | None | None | Epilepsy | 3 years | 1 |
| 10 | 13 | F | None | Insomnia | None | None | None | Headache | None | 1 year | 0 * |
| 11 | 9 | M | None | Insomnia | None | Depression | None | Headache | Congenital heart disease | 3-years | 1 |
| 12 | 14 | F | None | None | None | None | None | Headache | Breast discharge | 1-year | 1 |
| 13 | 15 | F | None | None | Migraine | None | None | None | None | 7-years | 1 |
| 14 | 17 | M | None | None | None | None | None | None | Epilepsy | 1-month | 1 |
| 15 | 7 | M | Cognitive dysfunction, attention problems | None | None | None | Constipation | None | Developmental delay | 7 years | 2 |
| 16 | 8 | F | None | None | Migraines | Anxiety | None | None | None | 3-months | 2 |
| 17 | 5 | F | None | None | None | None | Constipation | Headache, abdominal pain | None | 8-months | 1 |
| 18 | 8 | F | None | None | Migraine | None | None | None | None | 3-months | 1 |
| 19 | 5 | F | None | None | None | None | None | None | Febrile seizures | 2 years | 2 |
| 20 | 11 | M | Cognitive dysfunction | Insomnia | None | None | None | None | Epilepsy | 1-year | 2 |
| 21 | 15 | F | None | None | No | None | None | None | Epilepsy, Moyamoya disease | 3-years | 2 |
| 22 | 8 | M | None | Insomnia | Migraine | Anxiety | None | None | Cerebral dysgenesis | 7-years | 1 |
| 23 | 15 | M | Cognitive problems, memory problems | Insomnia | None | Anxiety | None | None | Epilepsy | 5-months | 2 |
| 24 | 13 | M | Learning problems, attention problems | Insomnia | Migraine | None | None | None | Neuro-fibromatosis Type-1 | 6 years | 0 * |
| 25 | 15 | F | Cognitive difficulties | None | Dizziness | Anxiety, depression, panic attacks | None | None | None | 1-year | 1 |
| 26 | 10 | F | None | None | None | None | None | Headache | Arnold Chiari malformation | 1-year | 1 |
| 27 | 10 | M | Cognitive dysfunction | Insomnia | None | None | None | Back pain | Cerebral palsy | 6-months | 1 |
* Other adverse childhood experience, not included the ACE score (motor vehicle accident, death of a loved one).